Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1986;73:1145-1154

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aylward, P. E.
Right arrow Articles by Abboud, F. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aylward, P. E.
Right arrow Articles by Abboud, F. M.

Circulation, Vol 73, 1145-1154, Copyright © 1986 by American Heart Association


ARTICLES

Effects of vasopressin on the circulation and its baroreflex control in healthy men

PE Aylward, JS Floras, WN Leimbach Jr and FM Abboud

Information on the hemodynamic effects of vasopressin (AVP) in healthy humans is very limited despite its known importance in body fluid homeostasis and release in pathologic states such as hemorrhage and trauma. Although it is a potent vasoconstrictor in vitro, it does not cause the expected rise in arterial pressure when given systemically to animals with intact baroreflexes. It has been proposed that this is because AVP facilitates baroreflex control of the circulation. In this study, we assessed the effect of infusion of AVP on resting circulatory variables and on the baroreflex control of forearm vascular resistance and heart rate in healthy men. AVP in a dose of 0.4 ng/kg/min, which raised plasma level of AVP to 24 +/- 4 pg/ml, a value known to have a significant antidiuretic effect, had little hemodynamic effect, producing only mild bradycardia and a slight increase in central venous pressure. Reflex changes in heart rate during neck suction (-15 and -30 mm Hg) and neck pressure (+15 and +30 mm Hg) were not altered. Reflex responses to lower body negative pressure and to its release were also unchanged by this dose of AVP. In contrast, a higher dose of AVP (4 ng/kg/min), which raised plasma levels to 290 +/- 41 pg/ml, a concentration known to occur as a result of hemorrhagic hypotension and circulatory stresses, did cause hemodynamic changes. There was tachycardia (from 63 +/- 2 to 68 +/- 2 beats/min), a decrease in pulse pressure (from 62 +/- 2 to 53 +/- 2 mm Hg), an increase in central venous pressure (from 2.6 +/- 0.5 to 4.1 +/- 0.4 mm Hg), and surprisingly in view of the known vasoconstrictor effect of AVP, an increase in forearm flow (from 4.4 +/- 0.7 to 5.9 +/- 1.2 ml/min/100 ml tissue) and a decrease in forearm vascular resistance (from 24 +/- 4 to 18 +/- 3 U); there was no significant change in mean arterial pressure (from 83 +/- 2 to 83 +/- 3 mm Hg). Reflex changes in heart rate were unaltered. The maximal vasoconstrictor response in the forearm attained during lower body negative pressure was not influenced by AVP, but the reflex vasodilator response to the sudden release of lower body negative pressure was significantly augmented, vascular resistance falling to 23 +/- 4 U before and 13 +/- 2 U during AVP. The unanticipated findings in this study include the biphasic changes in heart rate with increasing doses of AVP, the absence of a pressor response, and the vasodilatation in forearm vessels.(ABSTRACT TRUNCATED AT 400 WORDS)


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. V. Meck, W. W. Waters, M. G. Ziegler, H. F. deBlock, P. J. Mills, D. Robertson, and P. L. Huang
Mechanisms of postspaceflight orthostatic hypotension: low {alpha}1-adrenergic receptor responses before flight and central autonomic dysregulation postflight
Am J Physiol Heart Circ Physiol, April 1, 2004; 286(4): H1486 - H1495.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
M. W. Dunser, A. J. Mayr, H. Ulmer, N. Ritsch, H. Knotzer, W. Pajk, G. Luckner, N. J. Mutz, and W. R. Hasibeder
The Effects of Vasopressin on Systemic Hemodynamics in Catecholamine-Resistant Septic and Postcardiotomy Shock: A Retrospective Analysis
Anesth. Analg., July 1, 2001; 93(1): 7 - 13.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
G. J. Legris, D. Dearborn, R. C. Stern, C. L. Geiss, U. Hopfer, J. G. Douglas, and C. F. Doershuk
Sodium Space and Intravascular Volume: Dietary Sodium Effects in Cystic Fibrosis and Healthy Adolescent Subjects
Pediatrics, January 1, 1998; 101(1): 48 - 56.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Imai, C.-Y. Kim, J. Hashimoto, N. Minami, M. Munakata, and K. Abe
Role of Vasopressin in Neurocardiogenic Responses to Hemorrhage in Conscious Rats
Hypertension, January 1, 1996; 27(1): 136 - 143.
[Abstract] [Full Text]


Home page
Vasc MedHome page
P. Grant and P. Wiles
The role of 8-arginine vasopressin (antidiuretic hormone) in vascular homeostasis
Vascular Medicine, March 1, 1991; 2(1): 85 - 94.
[PDF]